Literature DB >> 15780805

Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA.

Chris Perrons1, Rosanne Jelley, Bernhard Kleter, Wim Quint, Nicola Brink.   

Abstract

BACKGROUND: HPV infection in young women is common. However only a certain number of HPV genotypes are oncogenic. It is necessary for high risk HPV infection to persist at the cervix for a considerable time before oncogenesis occurs.
OBJECTIVES: To look for persistence of high risk HPV in women attending a colposcopy clinic. Two DNA detection methods were used and the results compared to determine the rates of persistent, resolved and acquired infections over a 6-month period. HPV genotyping was used to determine type specific persistence. STUDY
DESIGN: One hundred and thirty-eight women were tested for HPV infection when attending the colposcopy clinic at UCLH and then tested again at a subsequent visit approximately 6 months later. HPV DNA was detected by the Digene HC II assay using the high risk probes only and by PCR with the SPF10 primer set. All SPF10 PCR-positive samples were then specifically genotyped by a Line Probe Assay (LiPA) [Kleter et al. 1999. J. Clin. Microbiol. 1999;37:2508].
RESULTS: At entry of the study high risk HPV was detected in 43% of the samples by Digene HC II and in 60% of the samples by SPF10/LiPA. Thirty-eight (28%) of the women had a true persistent infection with the same high risk HPV genotype over a median period of 6.3 months. Nine (7%) women resolved one HR HPV infection after their first colposcopy visit, but obtained a different high risk HPV infection by the time they were tested at their second visit as identified by LiPA. Thirty-seven (27%) of the 138 women had mixed HPV infections, representing 45% of all those infected.
CONCLUSIONS: The SPF10/LiPA assay detected more high risk infections than the Digene HC II assay. The Digene HC II assay was unable to distinguish between persistent infections with the same high risk genotype and those where the genotype had changed between visits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780805     DOI: 10.1016/j.jcv.2004.08.009

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  20 in total

1.  Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.

Authors:  François Coutlée; Danielle Rouleau; Patrick Petignat; Georges Ghattas; Janet R Kornegay; Peter Schlag; Sean Boyle; Catherine Hankins; Sylvie Vézina; Pierre Coté; John Macleod; Hélène Voyer; Pierre Forest; Sharon Walmsley; Eduardo Franco
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.

Authors:  Christopher Payan; Alexandra Ducancelle; Mohamed H Aboubaker; Julien Caer; Malena Tapia; Amelie Chauvin; Damien Peyronnet; Elodie Le Hen; Zohra Arab; Marie-Christine Legrand; Adissa Tran; Edith Postec; Françoise Tourmen; Martine Avenel; Chantal Malbois; Marie-Anne De Brux; Philippe Descamps; Francoise Lunel
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

3.  Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests.

Authors:  Matthew P Stevens; Elice Rudland; Suzanne M Garland; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Performance of a polymer-based DNA chip platform in detection and genotyping of human papillomavirus in clinical samples.

Authors:  T Schenk; T Brandstetter; A Zur Hausen; J Alt-Mörbe; D Huzly; J Rühe
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

5.  Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.

Authors:  Matthew P Stevens; Suzanne M Garland; Elice Rudland; Jeffrey Tan; Michael A Quinn; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948

6.  Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study.

Authors:  Walter J Koskinen; Kjell Brøndbo; Hanna Mellin Dahlstrand; Tapio Luostarinen; Timo Hakulinen; Ilmo Leivo; Anco Molijn; Wim G Quint; Tov Røysland; Eva Munck-Wikland; Antti A Mäkitie; Ilmari Pyykkö; Joakim Dillner; Antti Vaheri; Leena-Maija Aaltonen
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-08       Impact factor: 4.553

7.  Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia.

Authors:  A T Hesselink; M A P C van Ham; D A M Heideman; Z M A Groothuismink; L Rozendaal; J Berkhof; F J van Kemenade; L A F G Massuger; W J G Melchers; C J L M Meijer; P J F Snijders
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

8.  Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.

Authors:  Helen Trottier; Salaheddin Mahmud; José Carlos M Prado; Joao S Sobrinho; Maria C Costa; Thomas E Rohan; Luisa L Villa; Eduardo L Franco
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

9.  Validation of the SPF10 LiPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples.

Authors:  Barbara Dal Bello; Arsenio Spinillo; Paola Alberizzi; Stefania Cesari; Barbara Gardella; Enrico Maria Silini
Journal:  J Clin Microbiol       Date:  2009-05-27       Impact factor: 5.948

10.  Comparison of the novel human papillomavirus 4 auto-capillary electrophoresis test with the hybrid capture 2 assay and with the PCR HPV typing set test in the detection of high-risk HPV including HPV 16 and 18 genotypes in cervical specimens.

Authors:  Jin Hwa Hong; Seung Hun Song; Jong Kee Kim; Jeong Hyun Han; Jae Kwan Lee
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.